Published in J Mol Endocrinol on August 01, 1995
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Esophagitis associated with the use of alendronate. N Engl J Med (1996) 4.89
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy (2010) 3.12
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Brunner's gland hamartomas: clinical presentation and pathological features of 27 cases. Am J Gastroenterol (1995) 2.52
Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology (2000) 2.50
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
The calpain family and human disease. Trends Mol Med (2001) 2.38
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology (2001) 2.30
Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion. Cell (1987) 2.20
Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J (1996) 2.05
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab (2000) 2.00
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Calpain regulates actin remodeling during cell spreading. J Cell Biol (1998) 1.90
The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol (1992) 1.78
Crystal structure of calcium bound domain VI of calpain at 1.9 A resolution and its role in enzyme assembly, regulation, and inhibitor binding. Nat Struct Biol (1997) 1.78
Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem (1995) 1.74
Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc (2000) 1.67
Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc (2001) 1.65
Impact of endoscopist withdrawal speed on polyp yield: implications for optimal colonoscopy withdrawal time. Aliment Pharmacol Ther (2006) 1.63
N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons. Proc Natl Acad Sci U S A (1996) 1.62
EUS-guided fine-needle aspiration combined with flow cytometry and immunocytochemistry in the diagnosis of lymphoma. Gastrointest Endosc (2001) 1.59
Prevalence of IgA-antiendomysial antibody in asymptomatic low bone mineral density. Am J Gastroenterol (2001) 1.54
Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci (2000) 1.53
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem (2001) 1.42
Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport (1998) 1.39
Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc (1995) 1.35
25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int (2010) 1.34
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
The high molecular weight multicatalytic proteinase, macropain, exists in a latent form in human erythrocytes. Biochim Biophys Acta (1989) 1.24
Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis. Osteoporos Int (2010) 1.24
Casein zymography: a method to study mu-calpain, m-calpain, and their inhibitory agents. Arch Biochem Biophys (1995) 1.21
Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int (2010) 1.17
The calmodulin-binding site in alpha-fodrin is near the calcium-dependent protease-I cleavage site. J Biol Chem (1988) 1.17
Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem Biophys Res Commun (2000) 1.16
Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int (2004) 1.15
Endoscopic diagnosis and resection of esophageal granular cell tumors. Dis Esophagus (2011) 1.15
Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc (2001) 1.14
The calpain small subunit gene is essential: its inactivation results in embryonic lethality. IUBMB Life (2000) 1.14
Differences in ankle joint complex range of motion as a function of age. Foot Ankle (1993) 1.14
Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int (2006) 1.12
Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem Biophys Res Commun (1999) 1.11
Collagenous colitis: a clinicopathologic correlation. Mayo Clin Proc (1987) 1.10
TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. J Neurosci Res (2001) 1.10
The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J Neurotrauma (2001) 1.09
Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc (2001) 1.08
Calcium-activated neutral protease effects upon skeletal muscle sarcoplasmic reticulum protein structure and calcium release. J Biol Chem (1992) 1.08
Evidence for activation of caspase-3-like protease in excitotoxin- and hypoxia/hypoglycemia-injured neurons. J Neurochem (1998) 1.08
Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density. Bone (2010) 1.07
Differential proteolysis of the full-length form of the L-type calcium channel alpha 1 subunit by calpain. J Neurochem (1994) 1.07
A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J Neurosci (1995) 1.03
Women with previous fragility fractures can be classified based on bone microarchitecture and finite element analysis measured with HR-pQCT. Osteoporos Int (2012) 1.03
Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J Neurochem (1997) 1.02
Autoproteolysis of the small subunit of calcium-dependent protease II activates and regulates protease activity. J Biol Chem (1986) 1.02
A technical note on diluting semen for the haemocytometric determination of sperm concentration. Hum Reprod (1989) 1.02
Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum (2000) 1.01
Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer (1998) 1.01
ATP-stimulated proteolysis in soluble extracts of BHK 21/C13 cells. Evidence for multiple pathways and a role for an enzyme related to the high-molecular-weight protease, macropain. Arch Biochem Biophys (1988) 1.00
Diagnosis of foregut duplication cysts by endoscopic ultrasonography. Gastroenterology (1995) 0.99
Neuronal nitric oxide synthase and calmodulin-dependent protein kinase IIalpha undergo neurotoxin-induced proteolysis. J Neurochem (1997) 0.99
Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol (2001) 0.98
Autosomal dominant hypoparathyroidism with intracranial calcification outside the basal ganglia. Am J Med Genet (1989) 0.98
Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures. J Cereb Blood Flow Metab (2001) 0.97
Pulmonary infiltrates and eosinophilia associated with sulfasalazine. Mayo Clin Proc (1984) 0.97
Biomarkers in Barrett esophagus. Mayo Clin Proc (2001) 0.97
Direct release of parathyroid hormone fragments from functioning bovine parathyroid glands in vitro. J Clin Invest (1978) 0.96
Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. Arch Biochem Biophys (2000) 0.96
An unrecognized etiology for pyogenic hepatic abscesses in normal hosts: dental disease. Am J Gastroenterol (1992) 0.95
Molecular cloning and characterization of a novel caspase-3 variant that attenuates apoptosis induced by proteasome inhibition. Biochem Biophys Res Commun (2001) 0.95
Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis. Curr Med Res Opin (2004) 0.95
Acute gastrointestinal bleeding. Experience of a specialized management team. J Clin Gastroenterol (1992) 0.95
Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int (2010) 0.94
Influence of glial growth factor and Schwann cells in a bioresorbable guidance channel on peripheral nerve regeneration. Tissue Eng (2000) 0.94
Mechanical loading regime and its relationship to bone mineral density in children. Med Sci Sports Exerc (1993) 0.94
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2010) 0.93
Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation. Biochem Biophys Res Commun (2001) 0.93
Proteolytic cleavage of the integrin beta 4 subunit. Exp Cell Res (1994) 0.92
Comparison of two calcium-dependent proteinases from bovine heart. Biochim Biophys Acta (1984) 0.92
A Coomassie brilliant blue G-250-based colorimetric assay for measuring activity of calpain and other proteases. Anal Biochem (1993) 0.91
Workshop report: clinical CASA--the quest for consensus. Reprod Fertil Dev (1995) 0.91
Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. Neuroreport (1996) 0.91
Phosphorylation of connexin-32 by protein kinase C prevents its proteolysis by mu-calpain and m-calpain. J Biol Chem (1993) 0.91
Calcium/calmodulin-dependent protein kinase IV is cleaved by caspase-3 and calpain in SH-SY5Y human neuroblastoma cells undergoing apoptosis. J Biol Chem (1998) 0.91
Calpains mediate calcium and chloride influx during the late phase of cell injury. J Pharmacol Exp Ther (1997) 0.90
In vitro perifusion for the study of parathyroid hormone secretion: effects of extracellular calcium concentration and beta-adrenergic regulation on bovine parathyroid hormone secretion in vitro. Calcif Tissue Int (1980) 0.90
Calmodulin regulates fodrin susceptibility to cleavage by calcium-dependent protease I. J Biol Chem (1989) 0.90
Technology status evaluation report: computerized endoscopic medical record systems: November 1999. Gastrointest Endosc (2000) 0.89
Endogenous bax translocation in SH-SY5Y human neuroblastoma cells and cerebellar granule neurons undergoing apoptosis. J Neurochem (1999) 0.89
Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia. Am J Surg Pathol (2000) 0.89
Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol (1999) 0.89
Activation of apoptosis-linked caspase(s) in NMDA-injured brains in neonatal rats. Neurochem Int (2000) 0.89